1.
Bankar A, Siriwardena TP, Rizoska B, RydergÄrd C, Kylefjord H, Rraklli V, Eneroth A, Pinho P, Norin S, Bylund J, Moses S, Bethell R, Kavanagh S, Maclean N, Gronda M, Wang X, Hurren R, Minden MD, Targett-Adams P, Schimmer AD, Albertella M. Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia. Haematologica [Internet]. 2021Feb.1 [cited 2026Nov.19];106(2):574-9. Available from: https://haematologica.org/article/view/9579